Janet Coller
Janet Coller
Senior Lecturer in Pharmacology, the University of Adelaide
Verified email at adelaide.edu.au
TitleCited byYear
Pharmacogenetics of opioids
AA Somogyi, DT Barratt, JK Coller
Clinical Pharmacology & Therapeutics 81 (3), 429-444, 2007
3382007
ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individuals
JK Coller, DT Barratt, K Dahlen, MH Loennechen, AA Somogyi
Clinical Pharmacology & Therapeutics 80 (6), 682-690, 2006
1472006
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z‐4‐hydroxy‐tamoxifen in human liver
JK Coller, N Krebsfaenger, K Klein, K Endrizzi, R Wolbold, T Lang, ...
British journal of clinical pharmacology 54 (2), 157-167, 2002
1372002
CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes
MR Hutchinson, A Menelaou, DJR Foster, JK Coller, AA Somogyi
British journal of clinical pharmacology 57 (3), 287-297, 2004
1232004
Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence
JK Coller, MR Hutchinson
Pharmacology & therapeutics 134 (2), 219-245, 2012
1142012
Role of active metabolites in the use of opioids
JK Coller, LL Christrup, AA Somogyi
European journal of clinical pharmacology 65 (2), 121-139, 2009
1082009
Inhibiting the TLR4‐MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol‐induced sedation and motor impairment in mice
Y Wu, EL Lousberg, LM Moldenhauer, JD Hayball, JK Coller, KC Rice, ...
British journal of pharmacology 165 (5), 1319-1329, 2012
662012
Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment
Y Wu, EL Lousberg, LM Moldenhauer, JD Hayball, SA Robertson, ...
Brain, behavior, and immunity 25, S155-S164, 2011
662011
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms
JK Coller, AA Somogyi, F Bochner
British journal of clinical pharmacology 48 (2), 158, 1999
521999
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments
DT Barratt, JK Coller, AA Somogyi
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 …, 2006
512006
Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours
JK Coller, P Fritz, UM Zanger, I Siegle, M Eichelbaum, HK Kroemer, ...
The Histochemical journal 33 (6), 329-336, 2001
482001
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation
NA Helsby, CY Hui, MA Goldthorpe, JK Coller, MC Soh, PJ Gow, ...
British journal of clinical pharmacology 70 (6), 844-853, 2010
462010
Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography–electrospray mass spectrometry
TE Mürdter, J Coller, A Claviez, F Schönberger, U Hofmann, P Dreger, ...
Clinical chemistry 47 (8), 1437-1442, 2001
442001
Pharmacogenetics of opioid response
AA Somogyi, JK Coller, DT Barratt
Clinical Pharmacology & Therapeutics 97 (2), 125-127, 2015
432015
OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence
JK Coller, S Cahill, C Edmonds, AL Farquharson, M Longo, R Minniti, ...
Pharmacogenetics and genomics 21 (12), 902-905, 2011
432011
Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence
L Liu, MR Hutchinson, JM White, AA Somogyi, JK Coller
Pharmacogenetics and genomics 19 (11), 869-876, 2009
392009
Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4
JK Coller, AA Somogyi, F Bochner
Xenobiotica 29 (10), 973-986, 1999
391999
Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains
L Liu, JK Coller, LR Watkins, AA Somogyi, MR Hutchinson
Brain, behavior, and immunity 25 (6), 1223-1232, 2011
382011
ABCB1 haplotype and OPRM1 118A> G genotype interaction in methadone maintenance treatment pharmacogenetics
DT Barratt, JK Coller, R Hallinan, A Byrne, JM White, DJR Foster, ...
Pharmacogenomics and personalized medicine 5, 53, 2012
372012
Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms
HR Wardill, RJ Gibson, YZA Van Sebille, KR Secombe, JK Coller, ...
Molecular cancer therapeutics 15 (6), 1376-1386, 2016
362016
The system can't perform the operation now. Try again later.
Articles 1–20